VG1 is a synthetic pyrroloisoquinoline alkaloid currently under investigation as a therapeutic agent for malaria and other infectious diseases due to its ability to inhibit parasite growth. Pharmaceutical… Read more
VG1 is a synthetic pyrroloisoquinoline alkaloid currently under investigation as a therapeutic agent for malaria and other infectious diseases due to its ability to inhibit parasite growth. Pharmaceutical research and quality control laboratories rely on high-quality reference standards of this compound to support critical analytical workflows. This category includes VG1 alongside its specific impurities, metabolic breakdown products, and stable isotope-labelled derivatives, which are essential for rigorous impurity profiling and method validation. By utilizing these precise analytical tools, researchers can ensure accurate mass spectrometry quantification and verify the identity and purity of the parent drug during drug development. These compounds provide the necessary framework for maintaining stringent analytical standards when evaluating the pharmacokinetics and stability of this potential antimalarial candidate.